drugset / Trial / NCT00094341

Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes

NCT00094341

Phase 4 Completed 215 enrolled Amgen
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the preference of RA patients for the new Enbrel® (etanercept) pre-filled syringe in patients who are already taking Enbrel®.

Timeline

Start
2004-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic

Indications